Skip to main content
Hims

Trade: Will Hims & Hers Health (HIMS) beat quarterly earnings?

16% YES 84% NO

Opened · Settles

Resolution criteria on PolyGram: As of market creation, Hims & Hers Health is estimated to release earnings on May 11, 2026. The Street consensus estimate for Hims & Hers Health's GAAP EPS for the relevant quarter is $0.03 as of market creation. This market will resolve to "Yes" if Hims & Hers Health reports GAAP EPS greater than $0.03 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings documents. If Hims & Hers Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha.

PolyGram is an on-chain prediction market where you trade YES or NO outcome shares with real USDC on Polygon. For this market, buy YES if you believe the event will happen, or NO if you think it won't. Your maximum loss is your stake — winning shares pay $1.00 each at resolution. Unlike sportsbooks, there is no house edge: prices are set by supply and demand from other traders and reflect the crowd's real-time probability.

Liquidity
$27
Total Volume
$11K
24h Volume
$7K
Open Interest
$5K
Trade this market on PolyGram →

Market outcomes

Will Hims & Hers Health (HIMS) beat quarterly earnings? 16% YES84% NO

Market context

Hims & Hers Health will report first-quarter 2026 earnings on 11 May, with the Street consensus targeting GAAP EPS of $0.03. This market resolves "Yes" only if reported earnings exceed that threshold. The current order book on Polymarket prices a 30% probability of a beat, implying the market assigns roughly 70% odds to either a miss or an exact match.

Hims has historically demonstrated volatile earnings surprises relative to consensus. The telehealth sector's margin profile remains sensitive to patient acquisition costs, prescription volumes, and regulatory shifts around GLP-1 medications—a category that has driven significant revenue but with unpredictable demand elasticity. Comparable SaaS and healthcare-tech firms trading at similar valuations typically see beat rates between 45–55%, suggesting the current 30% probability reflects either elevated scepticism about Hims' execution or consensus estimates positioned conservatively.

Key catalysts ahead include any guidance revisions or commentary on GLP-1 market saturation, changes to insurance reimbursement policies, and quarterly patient metrics disclosed alongside earnings. Traders should monitor FDA actions on telehealth prescribing and competitor announcements from Amazon Pharmacy or traditional pharmacy chains entering the direct-to-consumer space. Recent quarterly results from comparable digital health platforms will also frame investor expectations in the weeks before the 11 May release.

Wikipedia Context

  • Hims & Hers Health

    Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.

  • HMS Hermes (R12)
    HMS Hermes (R12)

    HMS Hermes was a conventional British light aircraft carrier and the last of the Centaur class.

  • His Hero Is Gone
    His Hero Is Gone

    His Hero Is Gone was an influential American crust punk and neocrust band from Memphis, Tennessee. The band formed in 1995 from members of Copout, Man With Gun Lives Here, Union of Uranus and FaceDown. They disbanded in 1999, playing their last show in Memphis. They toured the U.S. extensively several times, as well as Europe and Japan.

  • HMS Hermes (95)
    HMS Hermes (95)

    HMS Hermes was a British aircraft carrier built for the Royal Navy and was the world's first ship to be designed as an aircraft carrier, although the Imperial Japanese Navy's Hōshō was the first to be commissioned. The ship's construction began during the First World War, but she was not completed until after the end of the war, having been delayed by multip

Resolution source

This market settles from the official outcome published at https://seekingalpha.com/. A proposer submits the final result to the UMA optimistic oracle on Polygon; the two-hour dispute window closes and payouts clear in USDC.

How to trade this market step by step

The mechanics for trading "Will Hims & Hers Health (HIMS) beat quarterly earnings?" are the same as any other PolyGram event contract. Each YES share resolves to $1 if the event happens, or $0 if it doesn't. The current price between 0¢ and 100¢ is the market's probability estimate, set live by the order book.

  1. Sign in on polygram.ink with your email — no full KYC under $1,500 lifetime trading volume.
  2. Deposit USDC on Polygon (lowest fees, ~$0.01 per transaction) or Ethereum. Funds credit after 12 confirmations.
  3. Pick a side. Buy YES if you believe the event will happen; buy NO if you think it won't. The current YES price reflects the market's collective probability.
  4. Size your position. If you stake 100 USDC at 16% YES, you'll receive shares that pay $625 if YES resolves true — a 525% gross return. If NO resolves, your shares are worth $0.
  5. Set risk controls (optional). Stop-loss, take-profit, and limit-order types all supported. Use the trade ticket's slippage box to cap your maximum entry price.
  6. Wait for resolution. When the event resolves on-chain via the UMA optimistic oracle, the winning side settles to 100¢ automatically and USDC hits your balance within seconds. Withdrawable to any wallet you control.

How active is this market?

$11K in lifetime turnover and $27 of resting liquidity puts this market in the below the median by volume for hims contracts on PolyGram. Order-book depth is thin — large orders may need to be split across the book or executed as limit orders.

Last 24 hours alone saw $7K in turnover, well above the lifetime daily-average for this market — a clear sign of news catalysing trader activity right now.

The market has been open for under a month — fresh enough that information asymmetry remains a real factor.

Higher-volume markets tend to have tighter spreads and faster price discovery — meaning the displayed YES/NO percentages are more likely to reflect the true crowd-implied probability rather than a single trader's directional view.

Key terms

YES / NO share
A binary outcome token that pays $1.00 if the underlying claim resolves true (YES) or false (NO), and $0 otherwise. The market price between 0¢ and 100¢ is the implied probability.
CLOB
Central limit order book. The matching engine that pairs YES buyers with NO buyers (effectively the same trade). Polymarket's CLOB on Polygon executes trades on-chain via the conditional-tokens framework.
Liquidity
USDC capital sitting in resting limit orders inside the order book. Deeper liquidity means smaller slippage on large trades and a tighter bid-ask spread.
UMA optimistic oracle
The on-chain dispute system that settles each Polymarket market. A proposer submits the outcome, a two-hour challenge window opens, and unchallenged proposals finalise the resolution.
Slippage
The difference between the displayed mid-price and your fill price. Affects market orders most; limit orders avoid slippage but may take time to fill.
Conditional token
ERC-1155 outcome share issued by Gnosis Conditional Tokens on Polygon. The token type that resolves to $1.00 or $0.00 at settlement.

See the full prediction-market glossary →

Frequently asked questions

What is the current probability for "Will Hims & Hers Health (HIMS) beat quarterly earnings?"?

As of today, traders on Polymarket price this outcome at 16%. The number updates continuously as the order book clears. PolyGram mirrors the same live odds with locale-aware formatting and USDC settlement.

How does this market resolve?

Resolution is sourced from https://seekingalpha.com/. Settlement is executed by the UMA optimistic oracle on Polygon, with a 2-hour dispute window before payouts clear.

When does this market close?

This prediction market is scheduled to close on 11 May 2026. After the resolving event occurs, settlement typically clears within 24 hours once the UMA optimistic oracle confirms the outcome. All payouts are in USDC on the Polygon network.

How can I trade on "Will Hims & Hers Health (HIMS) beat quarterly earnings?"?

To trade on this prediction market, create a free PolyGram account at polygram.ink, deposit USDC via Polygon, and place a YES or NO order on the outcome you believe in. You can learn more on our how-it-works page. Your maximum loss is limited to your stake — there is no leverage or margin.

What happens when the market resolves?

When the outcome is determined, winning YES shares pay out $1.00 each in USDC, while losing shares pay $0. Settlement is handled by the UMA optimistic oracle on Polygon — a proposer submits the result, a two-hour dispute window opens, and if uncontested, payouts are distributed automatically. You can withdraw your winnings to any Polygon wallet.

Risk and regulatory note

Prediction-market positions can lose 100% of staked capital. Outcomes are uncertain by definition — historical accuracy of crowd-implied probabilities is high in aggregate but not for any single market. PolyGram does not provide investment advice. Trade only with capital you can afford to lose.

Regulatory status varies by jurisdiction. Germany, the United States, and most EU countries treat Polymarket-style event contracts under one of three frameworks: financial derivative, gambling product, or unregulated novel asset. Consult local counsel before trading.

View live odds & trade →

Related prediction markets

Explore more prediction market odds and trading opportunities on PolyGram: